Report Thumbnail
Product Code LP0913210471ORY
Published Date 2023/2/7
English109 PagesGlobal

Global Lactic Acid Bacteria Tablet Market Growth 2023-2029ConsumerGoods_Retail Market


Report Thumbnail
Product Code LP0913210471ORY◆The Feb 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2023/2/7
English 109 PagesGlobal

Global Lactic Acid Bacteria Tablet Market Growth 2023-2029ConsumerGoods_Retail Market



Abstract


Summary

Lactic Acid Bacteria Tablet are probiotics that have been cultured to form tablets containing live lactic acid bacteria molecules and are mainly used for intestinal abnormalities, indigestion enteritis and other symptoms.
LPI (LP Information)' newest research report, the “Lactic Acid Bacteria Tablet Industry Forecast” looks at past sales and reviews total world Lactic Acid Bacteria Tablet sales in 2022, providing a comprehensive analysis by region and market sector of projected Lactic Acid Bacteria Tablet sales for 2023 through 2029. With Lactic Acid Bacteria Tablet sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lactic Acid Bacteria Tablet industry.
This Insight Report provides a comprehensive analysis of the global Lactic Acid Bacteria Tablet landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lactic Acid Bacteria Tablet portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Lactic Acid Bacteria Tablet market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lactic Acid Bacteria Tablet and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lactic Acid Bacteria Tablet.
The global Lactic Acid Bacteria Tablet market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Lactic Acid Bacteria Tablet is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Lactic Acid Bacteria Tablet is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Lactic Acid Bacteria Tablet is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Lactic Acid Bacteria Tablet players cover PROBIOTICAL, Park Pharmaceuticals, Biobrick Pharma, Sunfood Nutraceuticals, Mitsubishi Chemical Corporation, Trumac Healthcare, Taj Pharma Group, BJP Laboratories Pty Ltd and Torrent Pharmaceuticals Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Lactic Acid Bacteria Tablet market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Adults
Children
Segmentation by application
Online Sales
Offline Sales
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
PROBIOTICAL
Park Pharmaceuticals
Biobrick Pharma
Sunfood Nutraceuticals
Mitsubishi Chemical Corporation
Trumac Healthcare
Taj Pharma Group
BJP Laboratories Pty Ltd
Torrent Pharmaceuticals Ltd
China Resources (Holdings) Company Limited
Renhe Pharmac
Key Questions Addressed in this Report
What is the 10-year outlook for the global Lactic Acid Bacteria Tablet market?
What factors are driving Lactic Acid Bacteria Tablet market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lactic Acid Bacteria Tablet market opportunities vary by end market size?
How does Lactic Acid Bacteria Tablet break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Lactic Acid Bacteria Tablet Annual Sales 2018-2029
      • 2.1.2 World Current & Future Analysis for Lactic Acid Bacteria Tablet by Geographic Region, 2018, 2022 & 2029
      • 2.1.3 World Current & Future Analysis for Lactic Acid Bacteria Tablet by Country/Region, 2018, 2022 & 2029
    • 2.2 Lactic Acid Bacteria Tablet Segment by Type
      • 2.2.1 Adults
      • 2.2.2 Children
    • 2.3 Lactic Acid Bacteria Tablet Sales by Type
      • 2.3.1 Global Lactic Acid Bacteria Tablet Sales Market Share by Type (2018-2023)
      • 2.3.2 Global Lactic Acid Bacteria Tablet Revenue and Market Share by Type (2018-2023)
      • 2.3.3 Global Lactic Acid Bacteria Tablet Sale Price by Type (2018-2023)
    • 2.4 Lactic Acid Bacteria Tablet Segment by Application
      • 2.4.1 Online Sales
      • 2.4.2 Offline Sales
    • 2.5 Lactic Acid Bacteria Tablet Sales by Application
      • 2.5.1 Global Lactic Acid Bacteria Tablet Sale Market Share by Application (2018-2023)
      • 2.5.2 Global Lactic Acid Bacteria Tablet Revenue and Market Share by Application (2018-2023)
      • 2.5.3 Global Lactic Acid Bacteria Tablet Sale Price by Application (2018-2023)
  • 3 Global Lactic Acid Bacteria Tablet by Company

    • 3.1 Global Lactic Acid Bacteria Tablet Breakdown Data by Company
      • 3.1.1 Global Lactic Acid Bacteria Tablet Annual Sales by Company (2018-2023)
      • 3.1.2 Global Lactic Acid Bacteria Tablet Sales Market Share by Company (2018-2023)
    • 3.2 Global Lactic Acid Bacteria Tablet Annual Revenue by Company (2018-2023)
      • 3.2.1 Global Lactic Acid Bacteria Tablet Revenue by Company (2018-2023)
      • 3.2.2 Global Lactic Acid Bacteria Tablet Revenue Market Share by Company (2018-2023)
    • 3.3 Global Lactic Acid Bacteria Tablet Sale Price by Company
    • 3.4 Key Manufacturers Lactic Acid Bacteria Tablet Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Lactic Acid Bacteria Tablet Product Location Distribution
      • 3.4.2 Players Lactic Acid Bacteria Tablet Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    • 3.6 New Products and Potential Entrants
    • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Lactic Acid Bacteria Tablet by Geographic Region

    • 4.1 World Historic Lactic Acid Bacteria Tablet Market Size by Geographic Region (2018-2023)
      • 4.1.1 Global Lactic Acid Bacteria Tablet Annual Sales by Geographic Region (2018-2023)
      • 4.1.2 Global Lactic Acid Bacteria Tablet Annual Revenue by Geographic Region (2018-2023)
    • 4.2 World Historic Lactic Acid Bacteria Tablet Market Size by Country/Region (2018-2023)
      • 4.2.1 Global Lactic Acid Bacteria Tablet Annual Sales by Country/Region (2018-2023)
      • 4.2.2 Global Lactic Acid Bacteria Tablet Annual Revenue by Country/Region (2018-2023)
    • 4.3 Americas Lactic Acid Bacteria Tablet Sales Growth
    • 4.4 APAC Lactic Acid Bacteria Tablet Sales Growth
    • 4.5 Europe Lactic Acid Bacteria Tablet Sales Growth
    • 4.6 Middle East & Africa Lactic Acid Bacteria Tablet Sales Growth
  • 5 Americas

    • 5.1 Americas Lactic Acid Bacteria Tablet Sales by Country
      • 5.1.1 Americas Lactic Acid Bacteria Tablet Sales by Country (2018-2023)
      • 5.1.2 Americas Lactic Acid Bacteria Tablet Revenue by Country (2018-2023)
    • 5.2 Americas Lactic Acid Bacteria Tablet Sales by Type
    • 5.3 Americas Lactic Acid Bacteria Tablet Sales by Application
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Lactic Acid Bacteria Tablet Sales by Region
      • 6.1.1 APAC Lactic Acid Bacteria Tablet Sales by Region (2018-2023)
      • 6.1.2 APAC Lactic Acid Bacteria Tablet Revenue by Region (2018-2023)
    • 6.2 APAC Lactic Acid Bacteria Tablet Sales by Type
    • 6.3 APAC Lactic Acid Bacteria Tablet Sales by Application
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Lactic Acid Bacteria Tablet by Country
      • 7.1.1 Europe Lactic Acid Bacteria Tablet Sales by Country (2018-2023)
      • 7.1.2 Europe Lactic Acid Bacteria Tablet Revenue by Country (2018-2023)
    • 7.2 Europe Lactic Acid Bacteria Tablet Sales by Type
    • 7.3 Europe Lactic Acid Bacteria Tablet Sales by Application
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Lactic Acid Bacteria Tablet by Country
      • 8.1.1 Middle East & Africa Lactic Acid Bacteria Tablet Sales by Country (2018-2023)
      • 8.1.2 Middle East & Africa Lactic Acid Bacteria Tablet Revenue by Country (2018-2023)
    • 8.2 Middle East & Africa Lactic Acid Bacteria Tablet Sales by Type
    • 8.3 Middle East & Africa Lactic Acid Bacteria Tablet Sales by Application
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Lactic Acid Bacteria Tablet
    • 10.3 Manufacturing Process Analysis of Lactic Acid Bacteria Tablet
    • 10.4 Industry Chain Structure of Lactic Acid Bacteria Tablet
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Lactic Acid Bacteria Tablet Distributors
    • 11.3 Lactic Acid Bacteria Tablet Customer
  • 12 World Forecast Review for Lactic Acid Bacteria Tablet by Geographic Region

    • 12.1 Global Lactic Acid Bacteria Tablet Market Size Forecast by Region
      • 12.1.1 Global Lactic Acid Bacteria Tablet Forecast by Region (2024-2029)
      • 12.1.2 Global Lactic Acid Bacteria Tablet Annual Revenue Forecast by Region (2024-2029)
    • 12.2 Americas Forecast by Country
    • 12.3 APAC Forecast by Region
    • 12.4 Europe Forecast by Country
    • 12.5 Middle East & Africa Forecast by Country
    • 12.6 Global Lactic Acid Bacteria Tablet Forecast by Type
    • 12.7 Global Lactic Acid Bacteria Tablet Forecast by Application
  • 13 Key Players Analysis

    • 13.1 PROBIOTICAL
      • 13.1.1 PROBIOTICAL Company Information
      • 13.1.2 PROBIOTICAL Lactic Acid Bacteria Tablet Product Portfolios and Specifications
      • 13.1.3 PROBIOTICAL Lactic Acid Bacteria Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.1.4 PROBIOTICAL Main Business Overview
      • 13.1.5 PROBIOTICAL Latest Developments
    • 13.2 Park Pharmaceuticals
      • 13.2.1 Park Pharmaceuticals Company Information
      • 13.2.2 Park Pharmaceuticals Lactic Acid Bacteria Tablet Product Portfolios and Specifications
      • 13.2.3 Park Pharmaceuticals Lactic Acid Bacteria Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.2.4 Park Pharmaceuticals Main Business Overview
      • 13.2.5 Park Pharmaceuticals Latest Developments
    • 13.3 Biobrick Pharma
      • 13.3.1 Biobrick Pharma Company Information
      • 13.3.2 Biobrick Pharma Lactic Acid Bacteria Tablet Product Portfolios and Specifications
      • 13.3.3 Biobrick Pharma Lactic Acid Bacteria Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.3.4 Biobrick Pharma Main Business Overview
      • 13.3.5 Biobrick Pharma Latest Developments
    • 13.4 Sunfood Nutraceuticals
      • 13.4.1 Sunfood Nutraceuticals Company Information
      • 13.4.2 Sunfood Nutraceuticals Lactic Acid Bacteria Tablet Product Portfolios and Specifications
      • 13.4.3 Sunfood Nutraceuticals Lactic Acid Bacteria Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.4.4 Sunfood Nutraceuticals Main Business Overview
      • 13.4.5 Sunfood Nutraceuticals Latest Developments
    • 13.5 Mitsubishi Chemical Corporation
      • 13.5.1 Mitsubishi Chemical Corporation Company Information
      • 13.5.2 Mitsubishi Chemical Corporation Lactic Acid Bacteria Tablet Product Portfolios and Specifications
      • 13.5.3 Mitsubishi Chemical Corporation Lactic Acid Bacteria Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.5.4 Mitsubishi Chemical Corporation Main Business Overview
      • 13.5.5 Mitsubishi Chemical Corporation Latest Developments
    • 13.6 Trumac Healthcare
      • 13.6.1 Trumac Healthcare Company Information
      • 13.6.2 Trumac Healthcare Lactic Acid Bacteria Tablet Product Portfolios and Specifications
      • 13.6.3 Trumac Healthcare Lactic Acid Bacteria Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.6.4 Trumac Healthcare Main Business Overview
      • 13.6.5 Trumac Healthcare Latest Developments
    • 13.7 Taj Pharma Group
      • 13.7.1 Taj Pharma Group Company Information
      • 13.7.2 Taj Pharma Group Lactic Acid Bacteria Tablet Product Portfolios and Specifications
      • 13.7.3 Taj Pharma Group Lactic Acid Bacteria Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.7.4 Taj Pharma Group Main Business Overview
      • 13.7.5 Taj Pharma Group Latest Developments
    • 13.8 BJP Laboratories Pty Ltd
      • 13.8.1 BJP Laboratories Pty Ltd Company Information
      • 13.8.2 BJP Laboratories Pty Ltd Lactic Acid Bacteria Tablet Product Portfolios and Specifications
      • 13.8.3 BJP Laboratories Pty Ltd Lactic Acid Bacteria Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.8.4 BJP Laboratories Pty Ltd Main Business Overview
      • 13.8.5 BJP Laboratories Pty Ltd Latest Developments
    • 13.9 Torrent Pharmaceuticals Ltd
      • 13.9.1 Torrent Pharmaceuticals Ltd Company Information
      • 13.9.2 Torrent Pharmaceuticals Ltd Lactic Acid Bacteria Tablet Product Portfolios and Specifications
      • 13.9.3 Torrent Pharmaceuticals Ltd Lactic Acid Bacteria Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.9.4 Torrent Pharmaceuticals Ltd Main Business Overview
      • 13.9.5 Torrent Pharmaceuticals Ltd Latest Developments
    • 13.10 China Resources (Holdings) Company Limited
      • 13.10.1 China Resources (Holdings) Company Limited Company Information
      • 13.10.2 China Resources (Holdings) Company Limited Lactic Acid Bacteria Tablet Product Portfolios and Specifications
      • 13.10.3 China Resources (Holdings) Company Limited Lactic Acid Bacteria Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.10.4 China Resources (Holdings) Company Limited Main Business Overview
      • 13.10.5 China Resources (Holdings) Company Limited Latest Developments
    • 13.11 Renhe Pharmac
      • 13.11.1 Renhe Pharmac Company Information
      • 13.11.2 Renhe Pharmac Lactic Acid Bacteria Tablet Product Portfolios and Specifications
      • 13.11.3 Renhe Pharmac Lactic Acid Bacteria Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.11.4 Renhe Pharmac Main Business Overview
      • 13.11.5 Renhe Pharmac Latest Developments
  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.